institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

US Appeals Court Upholds West Virginia Restriction on Abortion Pill Sales

WEST VIRGINIA, UNITED STATES, JUL 18 – The 4th Circuit ruled states can restrict mifepristone despite FDA approval, with medication abortions comprising 63% of U.S. abortions in 2023, according to the Guttmacher Institute.

  • In a 2-1 decision, the U.S. Court of Appeals for the Fourth Circuit issued a ruling on July 15, 2025, holding that FDA approval does not override the 2022 Unborn Child Protection Act.
  • After the Dobbs v. Jackson Women’s Health Organization decision in 2022, West Virginia enacted its near-total abortion ban, and GenBioPro argued federal law preempted those restrictions.
  • The court wrote `“would upend the federal-state balance by supplanting every state law tangentially touching a federal domain.”` and noted GenBioPro Inc. argued the state cannot block access to its FDA-approved mifepristone.
  • Patrick Morrisey called the ruling `“big win”`, while Erin Hawley said `“rightly refused GenBioPro’s invitation to federalize the issue of abortion.”`
  • Across Republican-controlled states, medication abortions now account for more than half of all abortions in the U.S., and 28 states, including West Virginia, have laws that limit or ban their use, highlighting how states have adopted similar restrictions.
Insights by Ground AI
Does this summary seem wrong?

60 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 38% of the sources lean Left
38% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

JAMA Network broke the news in on Tuesday, July 15, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.